ALLMedicine™ Burkholderia Center
Research & Reviews 3,079 results
https://doi.org/10.1186/s12879-021-05910-5 10.1093/bmb/ldr007 10.1055/s-0034-1398389 10.1128/CMR.18.2.383-416.2005 10.4269/ajtmh.15-0405 10.1093/ofid/ofz008 10.3390/tropicalmed3010024 10.1016/S0140-6736(03)13374-0 10.1056/NEJMra1204699 10.1378/chest.108.5.1420 10.3201/eid2102.141045 10.3109/00313027909061954 10.1099/ijsem.0.001755 10.4269/ajtmh.18-0418 10.1093/cid/cir808 10.1186/s13104-016-2168-2 10.3855/jidc.6455 10.1016/j.jiac.2016.08.017 10.1086/520223 10.1016/S2542-5196(18)30172-4 10.4269/ajtmh.2010.10-0030
BMC Infectious Diseases; Alvarez-Hernandez G, Cruz-Loustaunau D et. al.
Feb 24th, 2021 - Melioidosis is an infectious disease caused by Burkholderia pseudomallei. In Mexico, the disease is rarely diagnosed in humans and there is no evidence of simultaneous environmental isolation of the pathogen. Here, we describe clinical profiles of...
https://doi.org/10.3201/eid2703.191769
Emerging Infectious Diseases; Wu B, Tong X et. al.
Feb 24th, 2021 - We report a case of melioidosis in China and offer a comparison of 5 commercial detection systems for Burkholderia pseudomallei. The organism was misidentified by the VITEK 2 Compact, Phoenix, VITEK mass spectrometry, and API 20NE systems but was ...
https://doi.org/10.1371/journal.pntd.0009016
PLoS Neglected Tropical Diseases; Nelson M, Nunez A et. al.
Feb 22nd, 2021 - Burkholderia pseudomallei is the causative agent of melioidosis, which is a Gram negative, facultative intracellular bacterium. Disease is prevalent in SE Asia and in northern Australia, as well as in other tropical and subtropical regions. Recent...
https://doi.org/10.1128/AAC.02230-20
Antimicrobial Agents and Chemotherapy; Fen SHY, Tandhavanant S et. al.
Feb 17th, 2021 - Melioidosis is an often fatal infection in tropical regions caused by an environmental bacterium, Burkholderia pseudomallei Current recommended melioidosis treatment requires intravenous β-lactam antibiotics such as ceftazidime (CAZ), meropenem (M...
https://doi.org/10.1128/AAC.02385-20
Antimicrobial Agents and Chemotherapy; Clayton NP, Jain A et. al.
Feb 17th, 2021 - Bacillus anthracis and Yersinia pestis, causative pathogens for anthrax and plague, respectively, along with Burkholderia mallei and B. pseudomallei are potential bioterrorism threats. Tebipenem pivoxil hydrobromide (TBP HBr, formerly SPR994), is ...
Drugs 35 results see all →
Clinicaltrials.gov 3,167 results
https://doi.org/10.1186/s12879-021-05910-5 10.1093/bmb/ldr007 10.1055/s-0034-1398389 10.1128/CMR.18.2.383-416.2005 10.4269/ajtmh.15-0405 10.1093/ofid/ofz008 10.3390/tropicalmed3010024 10.1016/S0140-6736(03)13374-0 10.1056/NEJMra1204699 10.1378/chest.108.5.1420 10.3201/eid2102.141045 10.3109/00313027909061954 10.1099/ijsem.0.001755 10.4269/ajtmh.18-0418 10.1093/cid/cir808 10.1186/s13104-016-2168-2 10.3855/jidc.6455 10.1016/j.jiac.2016.08.017 10.1086/520223 10.1016/S2542-5196(18)30172-4 10.4269/ajtmh.2010.10-0030
BMC Infectious Diseases; Alvarez-Hernandez G, Cruz-Loustaunau D et. al.
Feb 24th, 2021 - Melioidosis is an infectious disease caused by Burkholderia pseudomallei. In Mexico, the disease is rarely diagnosed in humans and there is no evidence of simultaneous environmental isolation of the pathogen. Here, we describe clinical profiles of...
https://doi.org/10.3201/eid2703.191769
Emerging Infectious Diseases; Wu B, Tong X et. al.
Feb 24th, 2021 - We report a case of melioidosis in China and offer a comparison of 5 commercial detection systems for Burkholderia pseudomallei. The organism was misidentified by the VITEK 2 Compact, Phoenix, VITEK mass spectrometry, and API 20NE systems but was ...
https://doi.org/10.1371/journal.pntd.0009016
PLoS Neglected Tropical Diseases; Nelson M, Nunez A et. al.
Feb 22nd, 2021 - Burkholderia pseudomallei is the causative agent of melioidosis, which is a Gram negative, facultative intracellular bacterium. Disease is prevalent in SE Asia and in northern Australia, as well as in other tropical and subtropical regions. Recent...
https://doi.org/10.1128/AAC.02230-20
Antimicrobial Agents and Chemotherapy; Fen SHY, Tandhavanant S et. al.
Feb 17th, 2021 - Melioidosis is an often fatal infection in tropical regions caused by an environmental bacterium, Burkholderia pseudomallei Current recommended melioidosis treatment requires intravenous β-lactam antibiotics such as ceftazidime (CAZ), meropenem (M...
https://doi.org/10.1128/AAC.02385-20
Antimicrobial Agents and Chemotherapy; Clayton NP, Jain A et. al.
Feb 17th, 2021 - Bacillus anthracis and Yersinia pestis, causative pathogens for anthrax and plague, respectively, along with Burkholderia mallei and B. pseudomallei are potential bioterrorism threats. Tebipenem pivoxil hydrobromide (TBP HBr, formerly SPR994), is ...
News 55 results
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mpm-medical-llc-issues-voluntary-nationwide-recall-regenecare-ha-hydrogel-due-burkholderia-cepecia
Summary Company Announcement Date: December 02, 2020 FDA Publish Date: December 02, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Burkholderia cepecia contamination. Company Name: MPM Medical, LLC Brand Name: Brand Na...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/centurion-labs-issues-voluntary-nationwide-recall-ninjacof-lot-200n1601-and-ninjacof-lot-201na1601
Summary Company Announcement Date: August 22, 2017 FDA Publish Date: February 06, 2018 Product Type: Drugs Food & Beverages Generic Drugs Reason for Announcement: Recall Reason Description Potential contamination with Burkholderia cepacia Company ...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mid-valley-pharmaceutical-llc-issues-voluntary-recall-doctor-manzanilla-cough-cold-and-doctor
Summary Company Announcement Date: August 30, 2017 FDA Publish Date: February 08, 2018 Product Type: Drugs Generic Drugs Reason for Announcement: Recall Reason Description Burkholderia Cepacia Company Name: Mid Valley Pharmaceutical Brand Name: Br...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mavidon-issues-voluntary-worldwide-recall-manufactured-products-including-lemonprepr-tubes-and
Summary Company Announcement Date: December 23, 2019 FDA Publish Date: January 08, 2020 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Burkholderia cepacia Company Name: Mavidon Brand Name: Brand Name(s) LemonPrep...
https://www.medscape.com/viewarticle/917018
Aug 18th, 2019 - Pfizer is recalling two lots of eletriptan hydrobromide (Relpax) 40-mg tablets because of potential contamination with Pseudomonas and Burkholderia bacteria, the company has announced. The drug is indicated for the acute treatment of migraine with...
